Skip to main content
Premium Trial:

Request an Annual Quote

Biotrove Closes $7M in VC Funding to Help Sell OpenArray and RapidFire Products

NEW YORK, March 8 (GenomeWeb News) - Biotrove announced today that it closed $7 million in round of private-equity funding, bringing to $15 million its total venture capital financing since July 2005.

 

The round, which was oversubscribed, will help the company sell its OpenArray and RapidFire products.

 

Investors included Catalyst Health and Technology Partners, Echelon Ventures, Fletcher Spaght, and CB Health Ventures.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.